111 related articles for article (PubMed ID: 9401277)
1. Flow cytometric analysis of Thy-1 expression in CD34-positive acute leukemia.
Inaba T; Shimazaki C; Sumikuma T; Takahashi R; Hirai H; Kikuta T; Sudo Y; Yamagata N; Ashihara E; Goto H; Fujita N; Yoshimura M; Nakagawa M
Int J Hematol; 1997 Oct; 66(3):315-23. PubMed ID: 9401277
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Thy-1 (CDw90) expression in CD34+ acute leukemia.
Holden JT; Geller RB; Farhi DC; Holland HK; Stempora LL; Phillips CN; Bray RA
Blood; 1995 Jul; 86(1):60-5. PubMed ID: 7540889
[TBL] [Abstract][Full Text] [Related]
3. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.
Wuchter C; Ratei R; Spahn G; Schoch C; Harbott J; Schnittger S; Haferlach T; Creutzig U; Sperling C; Karawajew L; Ludwig WD
Haematologica; 2001 Feb; 86(2):154-61. PubMed ID: 11224484
[TBL] [Abstract][Full Text] [Related]
4. Detection of cytogenetic aberrations both in CD90 (Thy-1)-positive and (Thy-1)-negative stem cell (CD34) subfractions of patients with acute and chronic myeloid leukemias.
Brendel C; Mohr B; Schimmelpfennig C; Müller J; Bornhäuser M; Schmidt M; Ritter M; Ehninger G; Neubauer A
Leukemia; 1999 Nov; 13(11):1770-5. PubMed ID: 10557051
[TBL] [Abstract][Full Text] [Related]
5. CD117/CD34 expression in leukemic blasts.
Wells SJ; Bray RA; Stempora LL; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
[TBL] [Abstract][Full Text] [Related]
6. Thy-1 expression on blast cells from adult patients with acute myeloid leukemia.
Kozii R; Wilson J; Persichetti J; Phelps V; Ball SE; Ball ED
Leuk Res; 1997 May; 21(5):381-5. PubMed ID: 9225063
[TBL] [Abstract][Full Text] [Related]
7. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo.
Blair A; Hogge DE; Ailles LE; Lansdorp PM; Sutherland HJ
Blood; 1997 May; 89(9):3104-12. PubMed ID: 9129012
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric analysis of Thy-1 expression in myelodysplastic syndrome.
Inaba T; Shimazaki C; Sumikuma T; Shimura K; Takahashi R; Hirai H; Ashihara E; Sudo Y; Murakami S; Haruyama H; Fujita N; Yoshimura M; Nakagawa M
Int J Hematol; 1998 Dec; 68(4):403-10. PubMed ID: 9885439
[TBL] [Abstract][Full Text] [Related]
9. Thy-1 (CDw90) and c-kit receptor (CD117) expression on CD34+ hematopoietic progenitor cells: a five dimensional flow cytometric study.
D'Arena G; Musto P; Cascavilla N; Carotenuto M
Haematologica; 1998 Jul; 83(7):587-92. PubMed ID: 9718862
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
[TBL] [Abstract][Full Text] [Related]
11. Positive selection for CD90 as a purging option in acute myeloid leukemia stem cell transplants.
Feller N; Kelder A; Westra G; Ossenkoppele GJ; Schuurhuis GJ
Cytometry B Clin Cytom; 2008 Jan; 74(1):9-16. PubMed ID: 18061946
[TBL] [Abstract][Full Text] [Related]
12. Detection of molecular targets on the surface of CD34+CD38- bone marrow cells in myelodysplastic syndromes.
Xie W; Wang X; Du W; Liu W; Qin X; Huang S
Cytometry A; 2010 Sep; 77(9):840-8. PubMed ID: 20662087
[TBL] [Abstract][Full Text] [Related]
13. Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry.
Kanter-Lewensohn L; Hellström-Lindberg E; Kock Y; Elmhorn-Rosenborg A; Ost A
Eur J Haematol; 1996 Mar; 56(3):124-9. PubMed ID: 8598230
[TBL] [Abstract][Full Text] [Related]
14. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
16. CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cells.
Murray LJ; Bruno E; Uchida N; Hoffman R; Nayar R; Yeo EL; Schuh AC; Sutherland DR
Exp Hematol; 1999 Aug; 27(8):1282-94. PubMed ID: 10428505
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic differences between putative hematopoietic stem cells and childhood B-cell precursor acute lymphoblastic leukemia cells.
Lamkin T; Brooks J; Annett G; Roberts W; Weinberg K
Leukemia; 1994 Nov; 8(11):1871-8. PubMed ID: 7526089
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD34 immunoperoxidase staining in paraffin sections of acute leukemia: comparison with flow cytometric immunophenotyping.
Hanson CA; Ross CW; Schnitzer B
Hum Pathol; 1992 Jan; 23(1):26-32. PubMed ID: 1371985
[TBL] [Abstract][Full Text] [Related]
19. CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivo.
Young JC; Lin K; Hansteen G; Travis M; Murray LJ; Jaing L; Scollay R; Hill BL
Exp Hematol; 1999 Jun; 27(6):994-1003. PubMed ID: 10378888
[TBL] [Abstract][Full Text] [Related]
20. AC133 antigen as a prognostic factor in acute leukemia.
Lee ST; Jang JH; Min YH; Hahn JS; Ko YW
Leuk Res; 2001 Sep; 25(9):757-67. PubMed ID: 11489469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
